Breast Cancer Metastasis and Drug Resistance

Challenges and Progress

427 Seiten, Taschenbuch

Kurzbeschreibung des Verlags

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Expertsalso discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.

• Reihe: Advances in Experimental Medicine and Biology
• ISBN: 9783030203030
• Sprache: Englisch
• Erscheinungsdatum: 05.09.2020
• Genre: Medizin/Nichtklinische Fächer
• Verlag: Springer International Publishing
• Herausgegeben von: Aamir Ahmad